WATSON 954 (Reclipsen desogestrel 0.15 mg / ethinyl estradiol 0.03 mg)

Generic Name: desogestrel/ethinyl estradiol

Pill imprint WATSON 954 has been identified as Reclipsen desogestrel 0.15 mg / ethinyl estradiol 0.03 mg.

Reclipsen is used in the treatment of polycystic ovary syndrome; endometriosis; birth control; abnormal uterine bleeding; gonadotropin inhibition and belongs to the drug class contraceptives. Not for use in pregnancy. Reclipsen desogestrel 0.15 mg / ethinyl estradiol 0.03 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for WATSON 954

Reclipsen desogestrel 0.15 mg / ethinyl estradiol 0.03 mg WATSON 954 Front
Reclipsen desogestrel 0.15 mg / ethinyl estradiol 0.03 mg WATSON 954 Back
Reclipsen desogestrel 0.15 mg / ethinyl estradiol 0.03 mg WATSON 954
Reclipsen
Generic Name:
desogestrel/ethinyl estradiol
Imprint:
WATSON
954
Strength:
desogestrel 0.15 mg / ethinyl estradiol 0.03 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Contraceptives
Pregnancy Category:
X - Not for use in pregnancy
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
52544-0954
Inactive Ingredients:
lactose anhydrous
silicon dioxide
D&C Yellow No. 10
corn starch
FD&C Blue No. 2
povidone
magnesium stearate
stearic acid
microcrystalline cellulose
alpha-tocopherol
aluminum oxide

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)